This fast track antibody is not yet fully characterized. It is subject to these terms and conditions


  • Product name
    Anti-hCG receptor antibody
    See all hCG receptor primary antibodies
  • Description
    Goat polyclonal to hCG receptor

    This product is a fast track antibody. It has been affinity purified and shows high titre values against the immunizing peptide by ELISA. Read the terms of use »

  • Host species
  • Species reactivity

    Predicted to work with: Human, Cynomolgus monkey, Common marmoset
  • Immunogen

    Synthetic peptide:


    , corresponding to C terminal amino acids 685-698 of Human hCG receptor according to NP_000224.2.

  • Positive control
    • Lysates of Human Brain, Placenta and Prostate and of cell lines Daudi, HeLa and K562.



  • Application notes
    This antibody gave a positive result in ELISA against the immunizing peptide. Antibody detection limit dilution 1:32,000.
    Western Blot: Preliminary experiments gave an approx 35kDa band in lysates of Human Brain, Placenta and Prostate and of cell lines Daudi, HeLa and K562 after 0.1µg/ml antibody staining. Please note that currently we cannot find an explanation in the literature for the band we observe given the calculated size of 78.6kDa according to NP_000224.2. The 35kDa band was successfully blocked by incubation with the immunizing peptide.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function
      Receptor for lutropin-choriogonadotropic hormone. The activity of this receptor is mediated by G proteins which activate adenylate cyclase.
    • Tissue specificity
      Gonadal and thyroid cells.
    • Involvement in disease
      Defects in LHCGR are a cause of familial male precocious puberty (FMPP) [MIM:176410]; also known as testotoxicosis. In FMPP the receptor is constitutively activated.
      Defects in LHCGR are the cause of luteinizing hormone resistance (LHR) [MIM:238320]; also known as Leydig cell hypoplasia in males. LHR is an autosomal recessive disorder characterized by unresponsiveness to luteinizing hormone, defective sexual development in males, and defective follicular development and ovulation, amenorrhea and infertility in females. Two forms of the disorder have been defined in males. Type 1 is a severe form characterized by complete 46,XY male pseudohermaphroditism, low testosterone and high luteinizing hormone levels, total lack of responsiveness to luteinizing and chorionic gonadotropin hormones, lack of breast development, and absent development of secondary male sex characteristics. Type 2, a milder form, displays a broader range of phenotypic expression ranging from micropenis to severe hypospadias.
    • Sequence similarities
      Belongs to the G-protein coupled receptor 1 family. FSH/LSH/TSH subfamily.
      Contains 6 LRR (leucine-rich) repeats.
      Contains 1 LRRNT domain.
    • Cellular localization
      Cell membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • Gonadotropin receptor antibody
      • Gpcr19-rs1 antibody
      • GTHR-II antibody
      • HHG antibody
      • LCGR antibody
      • LGR2 antibody
      • LH-R antibody
      • LH/CG R antibody
      • LH/CG-R antibody
      • LH/CGR antibody
      • LHCGR antibody
      • LHR antibody
      • LHRHR antibody
      • LSH R antibody
      • LSH-R antibody
      • LSHR_HUMAN antibody
      • Luteinizing hormone receptor antibody
      • Luteinizing hormone/choriogonadotropin receptor antibody
      • Lutropin choriogonadotropic hormone receptor antibody
      • Lutropin choriogonadotropic receptor antibody
      • Lutropin-choriogonadotropic hormone receptor antibody
      • ULG5 antibody
      see all


    ab59019 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab59019.
    Please use the links above to contact us or submit feedback about this product.


    Sign up